Milestone Pharmaceuticals Statistics
Total Valuation
MIST has a market cap or net worth of $66.93 million. The enterprise value is $52.03 million.
Important Dates
The next estimated earnings date is Monday, May 12, 2025, before market open.
| Earnings Date | May 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MIST has 66.26 million shares outstanding. The number of shares has increased by 44.83% in one year.
| Current Share Class | 53.35M |
| Shares Outstanding | 66.26M |
| Shares Change (YoY) | +44.83% |
| Shares Change (QoQ) | +0.13% |
| Owned by Insiders (%) | 0.53% |
| Owned by Institutions (%) | 38.48% |
| Float | 53.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 5.09 |
| P/TBV Ratio | 5.09 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.10, with a Debt / Equity ratio of 4.17.
| Current Ratio | 9.10 |
| Quick Ratio | 8.79 |
| Debt / Equity | 4.17 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.76 |
Financial Efficiency
Return on equity (ROE) is -277.55% and return on invested capital (ROIC) is -38.56%.
| Return on Equity (ROE) | -277.55% |
| Return on Assets (ROA) | -34.92% |
| Return on Invested Capital (ROIC) | -38.56% |
| Return on Capital Employed (ROCE) | -62.49% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.26M |
| Employee Count | 33 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -38.41% in the last 52 weeks. The beta is 1.38, so MIST's price volatility has been higher than the market average.
| Beta (5Y) | 1.38 |
| 52-Week Price Change | -38.41% |
| 50-Day Moving Average | 1.62 |
| 200-Day Moving Average | 1.65 |
| Relative Strength Index (RSI) | 43.75 |
| Average Volume (20 Days) | 4,363,022 |
Short Selling Information
The latest short interest is 2.56 million, so 3.87% of the outstanding shares have been sold short.
| Short Interest | 2.56M |
| Short Previous Month | 880,568 |
| Short % of Shares Out | 3.87% |
| Short % of Float | 4.83% |
| Short Ratio (days to cover) | 0.58 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -42.10M |
| Pretax Income | -48.41M |
| Net Income | -41.52M |
| EBITDA | -42.00M |
| EBIT | -42.10M |
| Earnings Per Share (EPS) | -$0.67 |
Full Income StatementBalance Sheet
The company has $69.70 million in cash and $54.80 million in debt, giving a net cash position of $14.90 million or $0.22 per share.
| Cash & Cash Equivalents | 69.70M |
| Total Debt | 54.80M |
| Net Cash | 14.90M |
| Net Cash Per Share | $0.22 |
| Equity (Book Value) | 13.15M |
| Book Value Per Share | 0.20 |
| Working Capital | 65.80M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$28.85 million and capital expenditures -$33,000, giving a free cash flow of -$28.88 million.
| Operating Cash Flow | -28.85M |
| Capital Expenditures | -33,000 |
| Free Cash Flow | -28.88M |
| FCF Per Share | -$0.44 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |